Для начала определимся, что есть Hardware. В общем случае — это какой-то полезный девайс. Девайс обычно состоит из трёх основных типов частей: корпус (механические части), печатные платы и электронные компоненты. Чтобы Hardware стало Open — нужно чтобы все эти компоненты распространялись под свободной лицензией. Конечно, для чертежей могут не подойти обычные лицензии, используемые для СПО, потому они должны быть соответствующим образом адаптированы. Теперь по пунктам: Механические части: некоторые части можно распечатать на 3D-принтере даже дома, другие можно выточить на станке. А можно заказа. Opening price 5 USD. View View & Bid. Additional Fees.  Pneumatic Hardware Insertion Press w/ 9" Throat, Stand (SOLD AS-IS - NO WARRANTY). Add to watchlist. Live. Opening price 5 USD. View View & Bid. Additional Fees.  KR Wilson 25 Ton Electric/Hydraulic H-Frame Press (SOLD AS-IS - NO WARRANTY). Add to watchlist. Live. Government Bids & Contracts in Texas. Looking for more state & federal bids? Start Your Free Trial. 1, Government Bids & RFPs in Texas. View: Post Date Soonest Bid Date Soonest.  Number Title Amendment Due Date & Time Status IFB Street Repair at Long Drive Townhomes Pre-Bid Agenda Amendment 1 Amendment 2 Amendment 3 Amendment 4 AM Open View Now. Book Order - A Small Story about the Sky Irving, Texas Active Bid / Owner: Public. Nov 19, Nov 24, Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date/Time 3BAM Book Order - A Small Story about the Sky 3-Bid Purchasing 11/19/ 11/24/ PM (CT) View Now.

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies.

Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital.

Recent acquisitions include a management services organization, open hardware bids in texas kr network of pharmacies, clinical laboratory, and medical device companies with new and approved products.

NuGenerex Immuno-Oncology NGIO is being spun out of Generex as a separate, independent public company to advance the platform Ii-Key technology, particularly in combination with the immune checkpoint inhibitors.

The access information for the investor conference call is as follows:. Conference ID — Generex Biotech nology Corporation www. He is joined by Bruce Poignant, a year Exchange veteran, together with a team of former Exchange officials.

I have known Dave Donohoe and Bruce Poignant for years, and the success of their firm that specializes in national exchange uplists speaks for itself. We are excited about working with them to file our uplist application with Nasdaq in the coming days.

Generex Biotechnology Corporation www. After discussing our listing with Nasdaq officials and our transfer agent Broadridge Financial Solutions, Inc. In addition, Generex has been working on the application for the up-listing, and we have notified the Nasdaq that we will be submitting the application in the coming days.

The listing on the Nasdaq exchange is the last piece in our overall plan we put forth in January and ends with our dividend to shareholders after we are listed. We are excited about the potential listing on Nasdaq, which will ensure our future and provide Generex with a significant benefit as it relates to raising capital and investor liquidity while building sustainable value for our shareholders. We will announce to our shareholders when the application is submitted.

The call updated investors on the previously announced dividend that will be paid to shareholders upon up-list to the NASDAQ national stock exchange. The potential merger of NuGenerex Immuno-Oncology with Kiromic offers significant value for our shareholders with the addition of three immunotherapy and AI platforms that augment our Ii-Key immunotherapeutic peptide vaccine technology.

We are extremely excited to launch our new healthcare services business, NCCS and NuGenerex Health to complete our vision of Generex as an end-to-end solutions provider for physicians and patients. Our company is poised for growth, and I remain committed to executing on our strategy to deliver value for our shareholders.

Moscato and three others, will be retired; the 20, million shares remaining in the Pool will be returned to Generex and put back into the Generex treasury once Generex achieves its up-list to NASDAQ and the dividend is paid. Generex noted that Mr. Moscato previously waived the dividend for the Pool shares.

For clarity, there are currently 60, shares outstanding. Of these only 34, shares are eligible for the dividend. Post dividend, there Open Hardware Bids In Texas Wikipedia will be 69, shares in the market, as the 20, Pool shares will be retired and returned to the Generex treasury, leaving only 9 million additional shares in the market than pre-dividend.

The retirement of over 20 million shares is huge for shareholders, as it significantly reduces investor dilution by one-third. As we approach our goal of bringing Generex back to a national exchange, I am happy to share our success with our shareholders and provide Generex with a strong foundation for growth.

Thirty days of process time after filing is customary. In addition, effective September 5,the U. Securities and Exchange Open hardware bids in texas kr shortened the settlement cycle for transactions in U.

Conversely, if stock is purchased after the record date but the trade settles before the ex-dividend date, the buyer will be entitled to the dividend and will receive it via the due bill process. Also, on the call, my management team and I will provide a complete corporate overview, an update on the exciting commercial launch of Excellagen, details on our go-forward strategy, and an introduction to our highly valuable, Open Hardware Bids In Texas Online restructured MSO platform.

The seal is granted to a product after the Podiatric Seals Committee, a standing committee of the American Podiatric Medical Association, evaluates and determines whether the product allows normal foot function and promotes open hardware bids in texas kr foot health.

Additionally, evidence of usefulness and safety must be established, either by an appropriately recognized laboratory or clinical investigation, or by the products meeting certain physical standards. A detailed review is conducted by each committee member on every product. The committee then sends its recommendation to the APMA Board of Trustees, which has the authorization to either accept or reject the recommendation.

Excellagen is a ready to use 3-dimensional wound conforming matrix that supports a favorable wound healing environment.

It is designed to accelerate granulation tissue growth by providing a structural scaffold for cellular migration and proliferation, and activates platelets, triggering the localized release of endogenous growth factors including Platelet-Derived Growth Factor PDGFa key biological mediator of wound healing. The process for receiving the seal is a rigorous evaluation of open hardware bids in texas kr utility and value, open hardware bids in texas kr our customers open hardware bids in texas kr feel confident in choosing Excellagen to manage open hardware bids in texas kr hard to heal wounds knowing that our best in class product meets the high standards set by the APMA.

In addition, this is a great affiliation with the APMA, and we look forward to working with them and all APMA member surgeons and podiatrists to help manage their diabetic foot ulcers using Excellagen. I would love to hear from APMA members about their experience in the use of Excellagen in managing their patients hard to heal wounds. With demonstrated superior clinical data and strong economic value, the seal adds additional reason on why we believe Excellagen will be a disruptive technology in the Regenerative Wound Care Market.

Equally as important is the impact Excellagen makes on patients with hard to heal wounds that are difficult to manage causing a poor quality of life. Together, the broad technology portfolio and deep pipeline opportunities provided in the merger position NuGenerex Immuno-Oncology on the forefront of cancer immunotherapy.

Kiromic, which is collaborating with MD Anderson Cancer Center, has multiple patented proprietary immuno-oncology platforms, including CAR-T, CAR NK, an oral vaccine delivery system, and DIAMOND AI, an artificial intelligence system with a multifaceted predictive algorithm that combines genomic sequencing, proteomic analysis, and clinical data to identify novel tumor mutations that can be targeted with immunotherapy.

Kiromic is led by its founder, Dr. Anderson Cancer Center. The Open hardware bids in texas kr technology enables rapid product development and a clear regulatory path for immunotherapeutic peptides that have been proven safe and effective for eliciting immune responses for cancer therapy. The future is bright for advancing immunotherapy as the new standard of care for cancer treatment. Details of the transaction can be found in the Generex 8K filing to be filed with the SEC in the coming days.

With the acquisitions Olaregen and Regentys, Generex has established a powerful regenerative medicine company with FDA cleared products and innovative therapies in clinical development to drive value and future open hardware bids in texas kr. We have created a wound care expert salesforce to help guide physicians on the optimal Excellagen dose for a given wound type. Our partnership with Generex will enable Olaregen to reach open hardware bids in texas kr potential as a world-class regenerative medicine company with innovative products in wound healing and tissue regeneration.

The Olaregen technology has the potential to disrupt the current wound care market. Prior to this time he held two positions at Millennium Pharmaceuticals; first as Program Director for Target Validation, where he presided over technology development efforts for Aventis and Cereon, and second as Director of Programs and Operations, Discovery Research. He received his Ph. Hortobagyi chairs the department of breast medical oncology and directs the Breast Cancer Research Program at the University of Texas M.

Anderson Cancer Center, where he also serves as professor of medicine and holds the Nellie B. Connally Chair in Breast Cancer. Hortobagyi's research includes combination chemotherapy regimens, presurgical chemotherapy, and targeted therapies for all stages of breast cancer. He has contributed more than articles to scientific journals, authored and co-authored 13 books, and contributed over chapters to textbooks. For his efforts in breast cancer research, Dr.

Hortobagyi has received worldwide honors. InDr. Ibrahim focuses his research efforts on vaccines in breast cancer, breast geriatric oncology, and treatment of resistant breast cancer.

He has published extensively on his research to improve outcomes for the most difficult to treat breast cancers. Jacobs has a long and distinguished career as a clinical researcher in the fields of breast oncology and lymphoma, with a focus on adjuvant and neo-adjuvant therapy.

For the last four years, Dr. The NSABP pioneered breast cancer studies that led to the establishment of lumpectomy plus radiation over mastectomy as the standard surgical treatment for breast can cer and was also the first group to demonstrate that adjuvant therapy treatment in Open Hardware Bids In Texas Inc addition to surgery could alter the natural history of breast cancer, increase survival rates, and prevent recurrence using tamoxifen and raloxifene.

In open hardware bids in texas kr to his work in oncology treatment protocols, Dr. Jacobs has also conducted considerable research on the logistics and management of the clinical trial process, particularly in oncology. He has led open hardware bids in texas kr efforts at the University of Pittsburgh Clinical Research Service to provide study development and implementation assistance, IRB processing, patient recruitment, study coordination, and specimen and data collection for all investigators conducting cancer-related studies at all UPMC Cancer Centers.

Jacobs received his MD from the University of Open hardware bids in texas kr, and has spent his career making the University of Pittsburgh Medical Center a leading institution in the field of oncology and cancer management. Knutson's current interests and research focuses on the immunology and immunotherapy of breast and ovarian cancers, both the basic immunobiology and clinical translation, including clinical trials.

The laboratory conducts research on cancer vaccines focuses on augmenting CD4 helper T cell immunity using open hardware bids in texas kr epitopes. These vaccine strategies are aimed at preventing the patients from relapsing after optimal conventional therapies. Adoptive T cell therapy open hardware bids in texas kr also being examined, a strategy that involves infusing high numbers of T cells into patients with active bulky malignancy.

In addition to his research, Dr. Knutson received his Ph. He is a renowned leader in the field of breast cancer, with Open Hardware Bids In Texas 40 an extensive publication record focused on biomarker targeting for the improvement of clinical outcomes.

To accomplish this goal, he has established an ongoing collaboration with Dr Kornelia Polyak to use SAGE Serial Analysis of Gene Expression to identify genes important in the interaction between cancerous breast epithelial cells and tumor associated stromal cells. His research laboratory is currently validating these proteins as potential targets through the use of small molecule inhibitors in in vitro and in vivo models of tumor-stromal interaction.

In addition to this ongoing project, Dr. Krop is directing directing or co-directing several clinical trials with the aim of identifying novel molecular predictors of response to conventional chemotherapeutic and molecularly targeted therapies. In these roles she has worked open hardware bids in texas kr community oncologists to develop trials that combine clinical and biologic endpoints yet remain feasible in non-academic settings.

Miller first honed her ability to coordinate multi-center trials as principal investigator for E, the first phase III trial to confirm the benefits of antiangiogenic therapy in patients with metastatic breast cancer.

Miller currently leads E, an international phase III trial investigating antiangiogenic therapy in the adjuvant setting. Miller completed internal medicine training at Hopkins, then returned to her native Midwest for fellowship training at Indiana University, serving as Chief Fellow in His clinical research group is involved in vaccine strategies and other approaches to stimulate the immune system to recognize and destroy tumors.

Her research interests include innovative new therapies for women with advanced breast cancer, evaluation of special circulating cells to help figure out response to therapy, complementary medicine, and supportive care. She has published many peer-reviewed papers and has given presentations on a variety of cancer-related topics.

With a summa cum laude undergraduate degree from Tufts University, Dr. Rugo received her M. Additionally, she completed a two-year post-doctoral fellowship in immunology at Stanford University. Robert E. Humphreys was the Chief Scientific Officer of Antigen Express from it's inception, and at the time of his retirement held the position of Executive Vice President.

He was a postdoctoral fellow of Dr.

Click to get the latest Buzzing content. Take A Sneak Peak At The Movies Coming Out This Week (8/12) Saoirse Ronan: the Hollywood woman we love to watch. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more. Browse our listings to find jobs in Germany for expats, including jobs for English speakers or those in your native language.

Ball Bearing Drawer Slides Sticking Animals Bench Wood Lathe For Sale Online